FALLON BAUER: Open Payments
NPI 1114279049 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,767 in 144 payments from 34 companies in 2025. Trend: 2023 $1,167 · 2024 $2,594 · 2025 $2,767
Food & beverage: $2,767
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $294 |
| ABBVIE INC. | 21 | $267 |
| PFIZER INC. | 17 | $190 |
| EMD Serono, Inc. | 7 | $185 |
| Teva Pharmaceuticals USA, Inc. | 10 | $147 |
| Amneal Pharmaceuticals LLC | 5 | $138 |
| Lilly USA, LLC | 6 | $134 |
| UCB, Inc. | 5 | $115 |
| Janssen Biotech, Inc. | 3 | $103 |
| Lundbeck LLC | 3 | $96 |
Products named: KESIMPTA, QULIPTA, AUSTEDO XR, NURTEC ODT, CREXONT, Rystiggo, VYEPTI, PURIFIED CORTROPHIN GEL.
Industry payments across MD — which companies pay providers there.
